For many years, health debates and trillion-dollar research efforts revolved around a single question: How long can human life be extended? Today, however, the direction of the conversation has shifted. The real issue is no longer merely the length of life, but how those years are lived.
The central question today is this:
“How long will I live?” or “How will I live?”
For decades, health discussions and extensive global research focused primarily on extending human lifespan. Today, the narrative is evolving. The focus has moved beyond longevity itself to the quality of the years we live.
In recent years, the concept of sustainability has become central across nearly every sector. Within healthcare, this idea has taken on a new dimension: sustainable healthy aging.
The conversation is no longer only about living longer. It is about being able to run a marathon at 70, remain productive at 80, and sustain the vitality and energy typically associated with one’s 20s. Increasingly, the discussion is moving toward this perspective.
This shift has also brought two concepts into greater prominence within the health literature: “aging well” and “longevity.”
At first glance, these two ideas appear quite similar. Both aim to support longer and healthier lives. However, they differ significantly in terms of their methodologies, clinical approaches, and scientific foundations.
Across the world today, researchers, clinics, and healthcare centers are essentially pursuing the same question: How can people not only live longer, but live better?
In recent years, the rapidly growing number of longevity clinics has begun addressing this question through a more technological and innovative perspective. The ambition of longevity medicine is particularly bold: to slow biological aging and optimize human performance.
These centers typically conduct comprehensive biomarker screenings, metabolic analyses, and assessments such as epigenetic testing or biological age measurements. Based on these findings, personalized nutrition and exercise programs are designed, and hormone balance is often evaluated as part of the process.
In some clinics, more experimental interventions are also incorporated. These may include intravenous infusions containing NAD+ or micronutrients, senolytic therapies—an experimental pharmaceutical approach aimed at targeting and eliminating senescent “zombie” cells that contribute to tissue damage—or plasma exchange procedures.
The scientific foundation behind many of these approaches lies in a field known as geroscience, which studies the biological mechanisms of aging. Researchers working in this area believe that by targeting the aging process itself, it may be possible to delay or reduce the onset of many age-related diseases, including cardiovascular disease, diabetes, and Alzheimer’s disease.
For the full article:
https://www.forbes.com.tr/yazar/meri-istiroti